Ahmad Sadr
Corporate Officer/Principal bei APELLIS PHARMACEUTICALS, INC.
Profil
Ahmad Sadr bekleidet die Position des Vice President-Technical Operations bei Apellis Pharmaceuticals, Inc. In der Vergangenheit hatte Herr Sadr die Position des Vice President-Technical Operations bei Vision Medicines, Inc. und Director-Outsourced Manufacturing bei Portola Pharmaceuticals, Inc. inne. Herr Sadr hat einen Hochschulabschluss von der Widener University und einen Bachelor-Abschluss von der University of Maryland.
Aktive Positionen von Ahmad Sadr
| Unternehmen | Position | Beginn |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ahmad Sadr
| Unternehmen | Position | Ende |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2017 |
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 01.05.2016 |
Ausbildung von Ahmad Sadr
| University of Maryland | Undergraduate Degree |
| Widener University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
